Problem drinking Mental and Behavioural Disorders Problem drinking
Conditions
Interventions
Method of randomisation: Automatically by computer (according to a computer generated random list), in blocks of eight.
Experimental group: The E-therapy program (www.alcoholdebaas.nl) consists of a
the patient sets a goal to quit drinking or reduce drinking, and in four steps learns to reach this goal. The experimental group receives treatment immediately after randomization. Treatment will last
Sponsors
Tactus Addiction Care Centre (The Netherlands)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Minimum age of 18 2. Minimum drinking amount of 14 (females) or 21 (males) standard units a week 3. Able to read and write in Dutch 4. Given informed consent
Exclusion criteria
Exclusion criteria: 1. Receiving professional help for their drinking problem 2. Severe physical or psychiatric illness 3. Treatment or medication for psychiatric illnesses during the past six months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Mean weekly alcohol consumption in standard units a week (weekly recall) 2. Proportion of patients achieving their drinking goal (abstinence or moderate drinking) 3. Proportion of subjects not at risk (drinking 21 units or less for men and 14 units or less for women) Timepoints of assessment: E = Experimental group C = Control group T0: Baseline (E and C) T1: Post-treatment (E) and pre-intervention (C) T2: 3 months after T1 (E) and post treatment (C) T3: 6 months after T1 (E) and 3 months after T2 (C) T4: 9 months after T1 (E) and 6 months after T2 (C) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Alcohol related problems, assessed by the Maudsley Addiction Profile ? Health Symptom Scale (MAP-HSS) 2. Health status, assessed by the 28-item General Health Questionnaire (GHQ) 3. Quality of life, assessed by the 5-item EuroQol-5D 4. Satisfaction Timepoints of assessment: E = Experimental group C = Control group T0: Baseline (E and C) T1: Post-treatment (E) and pre-intervention (C) T2: 3 months after T1 (E) and post treatment (C) T3: 6 months after T1 (E) and 3 months after T2 (C) T4: 9 months after T1 (E) and 6 months after T2 (C) | — |
Countries
Netherlands
Outcome results
None listed